SCIENCE & FUTURE
Five BioTech Companies in Life-Extension
Disruptive innovation in healthcare
“A good hockey player plays where the puck is. A great hockey player plays where is the puck is going to be.” — Wayne Gretzky
Recently, I have started investing in ARK-G companies. These companies work in CRISPR, targeted therapeutics, bioinformatics, molecular diagnostics, stem cells, and agricultural biology. All these efforts are massively contributing to life-extension — both through preventative and prescriptive methods.
Bold claims require bold evidence. These pieces of evidence are happening right before our eyes. There are biotech companies that are working and collaborating at an alarming rate in the field of life-extension.
So how exactly will life-extension happen? Or happening already?
While we love Apple products, Facebook, Amazon, the one thing none of them are doing is curing cancer. Or diseases. Making us healthier. Extending our lifespans.
Enter genomics. Amazing things are happening here. Clinical tests for the treatments of severe diseases like sickle cell, pediatric blindness, and beta-thalassemia are happening at a rapid pace.
